• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Agile Therapeutics Inc (NQ: AGRX )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Mar 25, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Agile Therapeutics Inc

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    AGRX Stock Earnings: Agile Therapeutics Misses EPS, Beats Revenue for Q1 2024
    AGRX stock results show that Agile Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
    From Agile Therapeutics, Inc.
    Via GlobeNewswire
    AGRX Stock Earnings: Agile Therapeutics Misses EPS, Misses Revenue for Q4 2023
    AGRX stock results show that Agile Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    Agile Therapeutics: Q4 Earnings Insights
    Via Benzinga
    Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
    From Agile Therapeutics, Inc.
    Via GlobeNewswire
    Agile Therapeutics's Earnings: A Preview
    Via Benzinga
    Agile Therapeutics's Earnings: A Preview
    Via Benzinga
    Why Agile Therapeutics (AGRX) Stock Is Down 60%
    Agile Therapeutics shares are trading lower by 61% during Tuesday's session. The company announced the suspension of its trading on the Nasdaq effective Tuesday. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Agile Therapeutics Announces Delisting from Nasdaq
    From Agile Therapeutics, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 22, 2024
    Companies Reporting Before The Bell • Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $0.54 per share on revenue of $9.20 million. 
    Via Benzinga
    Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
    Live Conference Call and Webcast at 8:30 a.m. ET 
    From Agile Therapeutics, Inc.
    Via GlobeNewswire
    Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
    Live Conference Call and Webcast at 8:30 a.m. ET 
    From Agile Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
    Elimination of Remaining Debt to Perceptive Advisors Leaves the Company’s Balance Sheet Debt Free 
    From Agile Therapeutics, Inc.
    Via GlobeNewswire
    Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of Etsy, Inc. 
    Via Benzinga
    What's Going On With Women Health Focused Agile Therapeutics Stock Today?
    Agile Therapeutics stock rises on premarket trading, exercising warrants for $4.8M gross proceeds with reduced exercise price of $1.25 per share. 
    Via Benzinga
    Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
    From Agile Therapeutics, Inc.
    Via GlobeNewswire
    Why Is Bel Fuse (BELFB) Stock Down 17% Today?
    Bel Fuse stock is falling on Thursday as investors in BELFB shares react to the company's lackluster Q4 2023 earnings report. 
    Via InvestorPlace
    Why Is Draganfly (DPRO) Stock Down 48% Today?
    Draganfly stock is down on Thursday after the company announced details for a $3.6 million public offering of DPRO shares. 
    Via InvestorPlace
    Why Is BuzzFeed (BZFD) Stock Up 101% Today?
    BuzzFeed stock is rising higher on Thursday as investors in BZFD react to it selling Complex for $108.6 million in cash. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why Is Agile Therapeutics (AGRX) Stock Up 87% Today?
    Agile Therapeutics stock is rising higher on Thursday with heavy trading of AGRX shares despite a lack of news from the company. 
    Via InvestorPlace
    Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
    Shares of NVIDIA Corporation (NASDAQ: NVDA) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong revenue... 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Pre-market stock movers are a hot topic on Thursday and we're starting the day with a breakdown of all the latest news this morning! 
    Via InvestorPlace
    5 Value Stocks In The Healthcare Sector
    Via Benzinga
    Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
    From Agile Therapeutics, Inc.
    Via GlobeNewswire
    The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost
    From Agile Therapeutics, Inc.
    Via GlobeNewswire
    A Look Into Healthcare Sector Value Stocks
    Via Benzinga
    Overview Of Value Stocks In The Healthcare Sector
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.